STOCK TITAN

Cardlytics (CDLX) Stock News

CDLX Nasdaq

Welcome to our dedicated page for Cardlytics news (Ticker: CDLX), a resource for investors and traders seeking the latest updates and insights on Cardlytics stock.

Cardlytics reports as a Nasdaq-listed commerce media platform that connects advertisers with consumers through publishers’ digital channels and a card-linked offer network. Company updates commonly cover revenue, billings, consumer incentives, partner-share costs, adjusted contribution, Adjusted EBITDA, and guidance tied to advertiser demand and publisher relationships.

Recurring announcements also address governance and equity compensation under its inducement plan, capital-structure matters, and strategic portfolio actions. Recent company history includes the completed divestiture of Bridg, the identity resolution and shopper intelligence platform that had used point-of-sale data for analytics, loyalty marketing, and measurement.

Rhea-AI Summary

Cardlytics (NASDAQ: CDLX) announced that Hy-Vee's RedMedia has joined their Rippl retail media network through their Bridg division. The partnership integrates more than 285 Hy-Vee grocery stores into Rippl's national consortium of regional grocers and convenience stores.

Through this collaboration, RedMedia will enhance its first-party data capabilities, develop off-site functionalities, and expand customer engagement. The partnership represents a significant expansion of Rippl's network footprint across nine Midwest states and strengthens the platform's ability to connect retailers, brands, and non-endemic partners.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.44%
Tags
none
-
Rhea-AI Summary

Cardlytics (NASDAQ: CDLX) has scheduled its second quarter 2025 financial results release for August 6, 2025, after market close. The company will host a conference call the same day at 5:00 PM ET to discuss the results.

Investors can access the live audio webcast through the company's investor relations website at ir.cardlytics.com or by registering through the provided link. Alternatively, participants can dial +1 800-549-8228 using Conference ID: 14299. A replay of the call will be available on the website following the presentation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.3%
Tags
-
Rhea-AI Summary

Cardlytics (NASDAQ: CDLX) has announced the launch of three new dashboards within its revamped Cardlytics Insights Portal, enhancing its data analytics offering for advertisers. The platform, built on Cardlytics' network with visibility into $5.8 trillion of annual consumer spend, introduces new Customer Insights dashboards focusing on brand affinity, customer migration, and loyalty insights.

The enhanced portal now features six comprehensive dashboards, including Market Summary, Competitor Insights, and Geographic Insights, providing advertisers with real-time access to first-party purchase data. Shake Shack has already integrated the portal into their weekly operations, particularly valuing the competitive share insights for leadership reporting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.47%
Tags
none
Rhea-AI Summary

Cardlytics (NASDAQ: CDLX) has announced the launch of Cardlytics Rewards Platform (CRP), a new solution that expands its publisher network beyond financial institutions. The platform enables merchants with digital channels and loyalty programs to become publishers on the Cardlytics network, offering card-linked offers to their customers.

The expansion allows Cardlytics to reach consumers in new verticals such as retail and restaurants. Through CRP, customers can opt-in to receive offers by connecting their bank accounts and earn rewards in the form of the publisher's loyalty currency. The company has already launched with its first CRP publisher, described as a leading digital sports platform, with plans to add more partners in the coming months.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.51%
Tags
none
-
Rhea-AI Summary
Cardlytics (NASDAQ: CDLX) reported Q1 2025 financial results showing declining performance across key metrics. Revenue decreased 8% YoY to $61.9 million, while billings fell 7% to $97.6 million. The company posted a net loss of $(13.3) million, or $(0.26) per share, though this improved from a $(24.3) million loss in Q1 2024. Monthly qualified users (MQUs) grew 12% YoY to 214.9 million, but adjusted contribution per user (ACPU) declined to $0.13 from $0.17. For Q2 2025, Cardlytics projects billings between $100-108 million (down 2-9% YoY) and revenue of $61-67 million (down 4-12% YoY). The company's management highlighted progress in platformization efforts and strategic cost management while acknowledging ongoing challenges.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.04%
Tags
-
Rhea-AI Summary

TTV Capital, an early-stage fintech venture capital firm, welcomes two industry veterans as venture partners: Lynne Laube, co-founder and former CEO of Cardlytics, and Rachel Hamilton, former CMO of Greenlight.

Laube, who led Cardlytics to $300 million in revenue and 180 million monthly users before stepping down in 2022, brings 30 years of business scaling expertise. Hamilton, credited for growing Greenlight's customer base to millions and achieving a $2.3B valuation, offers deep digital marketing experience from her time at Facebook.

The appointments mark TTV Capital's 25th year of fintech investing. Founded in Atlanta in 2000, TTV has invested in over 100 companies, with eight reaching $1B+ valuations. The firm's portfolio includes successful investments in Cardlytics, Featurespace, and Greenlight. Additionally, venture partner Paul Todd is transitioning to a full-time partner role.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Cardlytics (NASDAQ: CDLX) has announced the granting of 124,050 restricted stock units to 11 newly hired employees as employment inducements, approved by the Compensation Committee of Cardlytics' Board of Directors on April 24, 2025.

The grants, issued under the 2022 Inducement Plan in accordance with Nasdaq Listing Rule 5635(c)(4), feature a structured vesting schedule: 50% of the units will vest on the first anniversary of the grant date, with the remaining 50% vesting quarterly over the subsequent 12 months. Vesting is contingent upon continuous employment with Cardlytics.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.97%
Tags
none
-
Rhea-AI Summary

Cardlytics (NASDAQ: CDLX) has scheduled the release of its first quarter 2025 financial results for May 7, 2025, after market close. The company will host a conference call on the same day at 5:00 pm Eastern time (2:00 pm Pacific time).

Investors can access the live audio webcast through the Cardlytics Investor Relations website at ir.cardlytics.com or by registering through the provided link. A replay will be available on the website following the call. For those preferring to dial in, the conference call can be accessed at +1 800-549-8228 using Conference ID: 86123.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.87%
Tags
-
Rhea-AI Summary

Cardlytics (NASDAQ: CDLX) reported challenging fourth quarter and full year 2024 results, with significant revenue declines. Q4 revenue fell 17.0% to $74.0 million, while full-year revenue decreased 10.0% to $278.3 million.

The company posted a Q4 net loss of $(15.6) million, or $(0.31) per share, an improvement from the $(100.8) million loss in Q4 2023. The full-year 2024 net loss widened to $(189.3) million, or $(3.91) per share.

Key metrics showed mixed results with Cardlytics MAUs slightly decreasing to 167.3 million in Q4 2024, down 0.4% year-over-year, while full-year MAUs increased 3.0% to 166.9 million. ARPU declined 16.7% to $0.44 in Q4 and dropped 12.6% to $1.67 for the full year.

Management remains focused on delivering sequential improvements and positive Adjusted EBITDA in 2025, while investing in platform modernization and expanding partner networks.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.55%
Tags
Rhea-AI Summary

Cardlytics (NASDAQ: CDLX) has announced the granting of 225,800 restricted stock units to 18 newly hired employees as employment inducements. The grants, approved by the Compensation Committee of Cardlytics' Board of Directors on February 26, 2025, comply with Nasdaq Listing Rule 5635(c)(4) and were issued under the company's 2022 Inducement Plan.

The vesting schedule stipulates that 50% of the restricted stock units will vest on the first anniversary of the grant date, with the remaining 50% vesting quarterly over the subsequent 12 months, contingent upon continuous employment with Cardlytics.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.84%
Tags
none

FAQ

What is the current stock price of Cardlytics (CDLX)?

The current stock price of Cardlytics (CDLX) is $3.74 as of July 31, 2026.

What is the market cap of Cardlytics (CDLX)?

The market cap of Cardlytics (CDLX) is approximately 22.1M.